Jazz Pharmaceuticals
JAZZ
$131.75
Share price
-0.74%
Change (1 day)
-13.13%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - P/B ratio
P/B ratio as of September 2023 : 2.36
According to Jazz Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 2.36.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Jazz Pharmaceuticals - P/B ratio (from 2007 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.25 | 64.6% |
| 2021-12-31 | 1.97 | -22.04% |
| 2020-12-31 | 2.53 | -5.96% |
| 2019-12-31 | 2.69 | 4.21% |
| 2018-12-31 | 2.59 | -13.12% |
| 2017-12-31 | 2.98 | -14.46% |
| 2016-12-31 | 3.48 | -35.47% |
| 2015-12-31 | 5.39 | -25.56% |
| 2014-12-31 | 7.24 | 28.12% |
| 2013-12-31 | 5.65 | 105.14% |
| 2012-12-31 | 2.76 | -67.39% |
| 2011-12-31 | 8.45 | -67.18% |
| 2010-12-31 | 25.7 | -861.16% |
| 2009-12-31 | -3.38 | 562.88% |
| 2008-12-31 | -0.5102 | -107.77% |
| 2007-12-31 | 6.56 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.07 | 72.37% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | 39.2 | 1,561.80% | 🇺🇸 USA |
 Endo International
ENDPQ | -0.0006 | -100.02% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | 1.51 | -36.21% | 🇮🇱 Israel |